홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

3-(4-(4-Chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione

HCID 74989
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
137732-39-9
표준 SMILES
O=C1C(=O)c2ccccc2C(O)=C1C1CCC(c2ccc(Cl)cc2)CC1
InChIKey
BSJMWHQBCZFXBR-UHFFFAOYSA-N
분자식
C22H19ClO3
평균 분자량
366.8 g/mol
단동위원소 질량
366.1022722

개요

Atovaquone is a naphthoquinone compound having a 4-(4-chlorophenyl)cyclohexyl group at the 2-position and a hydroxy substituent at the 3-position. It has a role as an antifungal agent, an antimalarial, an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor, an EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor and an EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor. It is a hydroxy-1,4-naphthoquinone and a member of monochlorobenzenes.

이름 및 식별자

우선 이름
3-(4-(4-Chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione
IUPAC
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
영어명
cis-Atovaquone
분자식
C22H19ClO3
분자량
366.84

이름 및 동의어

3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dioneDTXSID209166943-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dioneRefChem:1066764DTXCID20888847630-425-2ATOVAQUONE95233-18-4MepronWellvonecis-AtovaquoneAcuvel
이름 더 보기
cis-Atovaquone-d4Atovaquone EP Imp BAtovaquone Impurity 17Atovaquone EP Impurity B (RC A)Atovaquone Impurity 2(Atovaquone EP Impurity B)Atovaquone EP Impurity B (Atovaquone Related Compound A)Atovaquone EP Impurity B (Atovaquone USP Related Compound A)
137732-39-9Atavaquone94015-53-9566C80Mepron (antipneumocystic)CIS-ATOVAQUONE (RACEMIC)Atovaquone EP Impurity BBW 566C

데이터베이스 식별자

CAS
137732-39-9、94015-53-9、95233-18-4

물성

구조 계산 물성보충 중

XLogP
5.2
극성 표면적
54.4 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
2
무거운 원자 수
26
형식 전하
0
복잡도
595

실험 및 물리화학적 성질

Drugs · 3건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals

LogP5.07
SolubilityPractically insoluble
Collision Cross Section174.53 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
40 °C · >40°C (dec.)
끓는 점
535 · 535.0±50.0 °C(Predicted)
밀도
1.349 · 1.349±0.06 g/cm3(Predicted)
저장 조건
Room Temperature, under inert atmosphere
용해도
클로로포름(약간 용해됨), 디클로로메탄(약간 용해됨, 아세토니트릴)
산도 계수 (pKa)
5.01 · 5.01±0.10(Predicted)
물리적 상태
고체
색상
연한 노란색에서 밝은 노란색까지
주요 응용
의약품(소분자)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

안전 데이터

wgk
3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC CodeP01AX06
Protein BindingAtovaquone is extensively bound to plasma proteins (99.9%) over the concentration range of 1 to 90 µg/mL.
Pharmacodynamics · 1건

Atovaquone is a highly lipophilic drug that closely resembles the structure [ubiquinone]. Its inhibitory effect being comparable to ubiquinone, atovaquone can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis in atovaquone-responsive parasites. Cytochrome bc1 complex (complex III) seems to serve as a highly discriminating molecular target for atovaquone in Plasmodia. There is no significant risk for myelosuppression associated with atovaquone, making this drug a beneficial therapeutic agent for recipients of bone marrow transplantation.

Mechanism of Action · 1건

The mechanism of action against <i>Pneumocystis carinii</i> has not been fully elucidated. In Plasmodium species, the site of action appears to be the cytochrome bc1 complex (Complex III). Several metabolic enzymes are linked to the mitochondrial electron transport chain via ubiquinone. Inhibition of electron transport by atovaquone will result in indirect inhibition of these enzymes. The ultimate metabolic effects of such blockade may include inhibition of nucleic acid and ATP synthesis. Atovaquone also has been shown to have good <i>in vitro</i> activity against <i>Toxoplasma gondii</i>.

Biological Half-Life2.2 to 3.2 days
Metabolism/MetabolitesSome evidence suggests limited metabolism (although no metabolites have been identified).
Absorption, Distribution and Excretion · 4건

The bioavailability of atovaquone is low and variable and is highly dependent on formulation and diet. Bioavailability of the suspension increases two-fold when administered with meals. When administered with food, bioavailability is approximately 47%. Without food, the bioavailability is 23%.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
PubChem CID
74989
DTXSID
DTXSID20916694
ChEMBL
CHEMBL471792、CHEMBL519462
ChEBI
CHEBI:575568
UNII
F1W7QUV0KI、Y883P1Z2LT
EC Number
689-795-9
Nikkaji
J1.549.967B、J389.528I

The half-life of atovaquone is long due to presumed enterohepatic cycling and eventual fecal elimination. There was little or no excretion of atovaquone in the urine (less than 0.6%).

0.60 ± 0.17 L/kg

10.4 +/- 5.5 ml/min [HIV-infected patients receiving IV administration]

응용 분야

용도cis-Atovaquone is the cis-isomer of Atovaquone (A793500), a hydroxynaphthoquinone derivative that inhibits mitochondrial electron transport.